CliffBio
small molecule

ATAZANAVIR SULFATE

ATAZANAVIR SULFATE

Loss of exclusivity—loss of exclusivity
CompanyAMNEAL EU LTD

Drug detail

Brand nameATAZANAVIR SULFATE
Active ingredientATAZANAVIR SULFATE
StrengthEQ 100MG BASE
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalJune 2020
Marketing statusDISCN

More from AMNEAL EU LTD

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.